Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  1. Note to Item 9: Represents 7,420,091 shares of Common Stock held by Jiangsu Hengrui Pharmaceuticals Co., Ltd. 2. Note to Item 11: This percentage is calculated based on 90,038,969 shares of Common Stock outstanding, as reported by the Issuer in its quarterly report on Form 10-Q filed with the Securities and Exchange Commission on September 8, 2026.


SCHEDULE 13G



 
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
 
Signature:/s/ Lau Kin Chun
Name/Title:Lau Kin Chun, Chief Financial Officer
Date:11/09/2026